This seems to be especially evident in VHL-defective ccRCC, where HIF-1 can have tumor suppressive effects, whereas HIF-2 appears to be the major player in tumorigenesis (22–24) and is associated with higher grade, stage and poor patient outcome (25, 26). Here, VHL is linked to nonpapillary renal cell carcinoma.